IGF-1 LR3 does not promote growth in late-gestation growth-restricted fetal sheep.
PEPTIDE RESEARCH TOPIC
IGF-1 LR3 Research Peptide
Explore IGF-1 LR3 research, analogue identity, IGF signaling, binding-protein interactions, animal evidence, and differences from approved IGF medicines.
TOPIC OVERVIEW
About IGF-1 LR3
Identity and names
IGF-1 LR3, also called Long R3 IGF-I, is a modified analogue of insulin-like growth factor I. It differs from native IGF-I and mecasermin.
Compound type
It is an engineered protein analogue, not growth hormone. Sequence and expression-tag differences can change the identity of a laboratory reagent.
Mechanism
Research studies IGF receptor activity and altered interactions with IGF-binding proteins. Experimental exposure cannot be inferred from native IGF-I physiology.
Research focus and evidence
Published studies include animal growth, metabolism, and reagent characterization. Results from fetal or neonatal animal models do not establish adult human benefits.
Regulatory status and limits
Approval of an IGF-I medicine does not confer approval on LR3 analogues. Product-specific analytical identity and clinical evidence remain necessary.
Topics covered
- IGF analogue identity
- binding proteins
- animal growth studies
- native IGF-I comparisons
Common names and related terms: IGF-1 LR3, Long R3 IGF-I, LR3 IGF-1
RESEARCH SUMMARY
What Is IGF-1 LR3?
LAST VERIFIEDOctober 7, 2026
A study of growth-restricted fetal sheep found that a one-week IGF-1 LR3 infusion did not improve fetal growth and reduced circulating amino acids. This model-specific result does not establish clinical performance or bodybuilding benefits. IGF-1 LR3 fetal-sheep study
An analytical study detected His-tagged Long-R3-IGF-I in a black-market product. It highlights why a product name alone cannot establish sequence identity, purity, or equivalence to a studied reagent. Long-R3-IGF-I product characterization
EVIDENCE PROFILE
IGF-1 LR3 Research Evidence
A concise view of registered clinical research, PubMed-indexed literature, evidence stage, and important limitations.
LAST VERIFIEDOctober 7, 2026
Registered records0
Active studies0
Completed studies0
PubMed records86
Compound typeIt is an engineered protein analogue, not growth hormone. Sequence and expression-tag differences can change the identity of a laboratory reagent.
AliasesIGF-1 LR3, Long R3 IGF-I, LR3 IGF-1
Evidence stagePublished studies include animal growth, metabolism, and reagent characterization. Results from fetal or neonatal animal models do not establish adult human benefits.
U.S. regulatory contextApproval of an IGF-I medicine does not confer approval on LR3 analogues. Product-specific analytical identity and clinical evidence remain necessary.
Selected registered research
No matching intervention record was found in ClinicalTrials.gov during this verification. This does not mean that no research exists.
Selected PubMed records
Detection of His-tagged Long-R³-IGF-I in a black market product.
Recombinant expression of IGF-1 and LR3 IGF-1 fused with xylanase in Pichia pastoris.
How to interpret this profile
Registry and publication counts describe discoverable records, not proof of effectiveness or safety. Study design, compound identity, population, endpoints, and regulatory context must be reviewed individually.
START HERE
Essential IGF-1 LR3 guides
What Is IGF-1 LR3 Used For? Peptide GuideIGF-1 LR3 is a lab-made version of insulin-like growth factor 1. Learn what IGF-1 LR3 is used for, how it works in research, and key safety concerns.How Does IGF-1 LR3 Work? Mechanism, Effects, and SafetyHow does IGF-1 LR3 work? Learn how this long-acting IGF-1 analog binds receptors, what research shows, dosing debates, and key safety concerns.Does IGF-1 LR3 Work? What the Evidence ShowsDoes IGF-1 LR3 work? Learn what research really shows about its half-life, muscle-growth claims, side effects, and legal status in the United States.
IGF-1 LR3 KNOWLEDGE ARTICLESPage 1 of 2
KNOWLEDGE ARTICLE
↗IGF-1 LR3 Research Peptides: What Scientists Study
IGF-1 LR3 research peptides explained: how this long-acting IGF-1 analog works, how it compares to IGF-1 DES, and what lab buyers should verify.
KNOWLEDGE ARTICLE
↗How Long Does It Take for IGF-1 LR3 to Work?
How long does it take for IGF-1 LR3 to work? Users often report early changes in 1–2 weeks and fuller results by 4–6 weeks. Learn the timeline and safety.
KNOWLEDGE ARTICLE
↗How Does IGF-1 LR3 Make You Feel? Effects Explained
Wondering how does IGF-1 LR3 make you feel? Learn reported effects like energy, hunger, and tingling, plus safety facts and legal status in the US.
KNOWLEDGE ARTICLE
↗Is IGF-1 LR3 a Steroid? Facts, Effects, and Safety
Is IGF-1 LR3 a steroid? No, it is a modified peptide hormone, not an anabolic steroid. Learn how it works, legal status, safety, and research context.
KNOWLEDGE ARTICLE
↗CJC-1295 vs IGF-1 LR3: Key Differences Explained
CJC-1295 vs IGF-1 LR3 explained: how each works, half-life, side effects, and legal status. Learn the key differences before considering research use.
KNOWLEDGE ARTICLE
↗IGF-1 LR3 Benefits: Muscle Growth and Safety
IGF-1 LR3 benefits are often discussed for muscle growth and recovery. Learn how this peptide works, what research suggests, and safety concerns.
KNOWLEDGE ARTICLE
↗IGF-1 LR3 Results: What Users Report and What to Expect
IGF-1 LR3 results vary widely — here's what users report about gains, side effects, and cycles, plus why this research peptide isn't FDA-approved.
KNOWLEDGE ARTICLE
↗Can You Take IGF-1 LR3 and CJC-1295 Together?
Can you take IGF-1 LR3 and CJC-1295 together? Here's how the two research peptides overlap on the GH/IGF-1 axis, plus the safety and legal issues.
KNOWLEDGE ARTICLE
↗IGF-1 LR3 vs Tesamorelin: What Reddit Users Say
IGF-1 LR3 vs tesamorelin reddit discussions compare two popular peptides. Here's how they differ in mechanism, research use, dosing, and safety.
KNOWLEDGE ARTICLE
↗Is IGF-1 LR3 Safe? Risks, Legality, and What to Know
Is IGF-1 LR3 safe? It is not FDA-approved for human use, and human safety data is thin. Learn the reported side effects, legal risks, and research limits.
KNOWLEDGE ARTICLE
↗Does IGF-1 LR3 Increase Testosterone? Facts Explained
Does IGF-1 LR3 increase testosterone? Learn what research shows about IGF-1 LR3 and testosterone, how the peptide works, and safety concerns.
KNOWLEDGE ARTICLE
↗Does IGF-1 LR3 Make You Stronger? What Research Shows
Does IGF-1 LR3 make you stronger? Here's what research shows about IGF-1 LR3, muscle growth, strength gains, recovery, and safety for athletes.
KNOWLEDGE ARTICLE
↗IGF-1 LR3 Dosage Per Day: Research Guide
IGF-1 LR3 dosage per day varies by goal, experience, and reconstitution. This research guide covers typical community ranges, timing, and safety limits.
KNOWLEDGE ARTICLE
↗IGF-1 LR3 and Tesamorelin Stack: What to Know
The IGF-1 LR3 and tesamorelin stack pairs a growth hormone secretagogue with an IGF-1 analog. Learn how they differ, timing, risks, and safety.
KNOWLEDGE ARTICLE
↗IGF-1 LR3 vs Sermorelin: Key Differences Explained
IGF-1 LR3 vs sermorelin: how these two peptides differ in mechanism, half-life, FDA status, and side effects — plus what research actually shows.
KNOWLEDGE ARTICLE
↗HGH vs IGF-1 LR3: Differences, Effects, and Safety
HGH vs IGF-1 LR3 compared: how each works, typical bodybuilding use, side effects, legality, and why neither is FDA-approved for human performance.
KNOWLEDGE ARTICLE
↗IGF-1 LR3 Cutting Cycle: What You Need to Know
An IGF-1 LR3 cutting cycle is a research peptide protocol some people ask about for fat loss. Learn how it works, safety concerns, and legal status.
KNOWLEDGE ARTICLE
↗CJC 1295 vs IGF-1 LR3: Key Differences Explained
Comparing cjc 1295 vs igf-1 lr3? See how these peptides differ in mechanism, half-life, research use, and safety, plus how they are studied together.
KNOWLEDGE ARTICLE
↗Tesamorelin vs IGF-1 LR3: Key Differences Explained
Tesamorelin vs IGF-1 LR3: compare how these two peptides work, their FDA status, dosing differences, safety risks, and whether stacking them makes sense.
KNOWLEDGE ARTICLE
↗What to Stack with IGF-1 LR3? Safe Stacking Guide
Wondering what to stack with IGF-1 LR3? Compare common research peptide pairings, timing, risks, and why no stack is FDA-approved for human use.